Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Rees

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Nature Cancer|December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancersMarc Payton, Brian Belmontes, Kelly Hanestad, et al.
Cancer Discovery|July 14, 2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar RhabdomyosarcomaSusu Zhang, Kathleen L Engel, Assil Fahs, et al.
Molecular Cancer Therapeutics|December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative StressMarissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Cancer Discovery|September 2, 2025
Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complexLinjie Yuan, Wenzhi Ji, Brendan G Dwyer, et al.
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Molecular Cancer Research : MCR|August 30, 2019
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian CancerElizabeth H Stover, Maria B Baco, Ofir Cohen, et al.
Cell Reports|August 29, 2019
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid TumorsElaine M Oberlick, Matthew G Rees, Brinton Seashore-Ludlow, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolismKeene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletionsLinda Julian, Lisa Crozier, Devon Lukow, et al.
Cell Chemical Biology|September 9, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolismKeene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Nature Cancer|December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancersMarc Payton, Brian Belmontes, Kelly Hanestad, et al.
Cancer Discovery|July 14, 2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar RhabdomyosarcomaSusu Zhang, Kathleen L Engel, Assil Fahs, et al.
Molecular Cancer Therapeutics|December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative StressMarissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Cancer Discovery|September 2, 2025
Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complexLinjie Yuan, Wenzhi Ji, Brendan G Dwyer, et al.
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Molecular Cancer Research : MCR|August 30, 2019
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian CancerElizabeth H Stover, Maria B Baco, Ofir Cohen, et al.
Cell Reports|August 29, 2019
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid TumorsElaine M Oberlick, Matthew G Rees, Brinton Seashore-Ludlow, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolismKeene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletionsLinda Julian, Lisa Crozier, Devon Lukow, et al.
Cell Chemical Biology|September 9, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolismKeene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Pageof 8